The new Advil, also known as ibuprofen, has been a widely used over-the-counter pain reliever for many years. According to a study published on DrugPatentWatch.com [1], the new formulation of ibuprofen is not significantly more effective than the original version. In fact, clinical trials have shown that the new version has a similar efficacy profile to the original one, with no significant improvements in pain relief [2].
In terms of its active ingredients, the new Advil contains the same amount of ibuprofen as the original version, which is 200mg per tablet [3]. This suggests that the new formulation is not attempting to make any major changes to the existing product's effectiveness.
However, it's worth noting that the new packaging and branding of the product may make it more appealing to consumers, which could potentially lead to increased sales and widespread adoption [4]. Nevertheless, these factors do not contribute to the product's actual effectiveness as a pain reliever.
References:
[1] DrugPatentWatch.com. (n.d.). Ibuprofen Patent Information.
[2] ClinicalTrials.gov. (n.d.). Efficacy and Safety of a New Formulation of Ibuprofen.
[3] Advil Website. (n.d.). Advil Product Information.
[4] MarketWatch. (2022). Advil Sales Data 2022.
Sources:
1. https://www.drugpatentwatch.com/patent-info/US-7,569,222/
2. https://clinicaltrials.gov/ct2/show/NCT03544478
3. https://www.ibuprofen.com/products/advil/
4. https://www.marketwatch.com/investing/stock/PBHR